Phase I pharmacokinetic and safety analysis of epothilone folate (BMS-753493): First-in human clinical experience of a folate receptor-targeted chemotherapeutic agent administered on days 1, 4, 8, and 11 of a 21-day cycle Meeting Abstract
| Authors: | De Jonge, M. J.; Sleijfer, S.; Martin, L. P.; Marshall, J.; Deeken, J. F.; Konner, L. A.; Aghajanian, C.; BMS Phase I Clinical Research Team |
| Abstract Title: | Phase I pharmacokinetic and safety analysis of epothilone folate (BMS-753493): First-in human clinical experience of a folate receptor-targeted chemotherapeutic agent administered on days 1, 4, 8, and 11 of a 21-day cycle |
| Meeting Title: | 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 28 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2010 Jun 4-8 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2010-05-20 |
| Start Page: | 230s |
| Language: | English |
| ACCESSION: | WOS:000208852003198 |
| DOI: | 10.1200/jco.2010.28.15_suppl.2607 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 2607 -- Source: Wos |
